NanoViricides’ NV-387 Emerges as a Promising Broad-Spectrum Antiviral Against COVID-19 and Bird Flu
In the face of evolving viral threats such as the emerging COVID-19 variant NB1.8.1 ‘Nimbus’ and highly pathogenic Bird Flu strains, NanoViricides, Inc. has positioned its antiviral candidate NV-387 as a critical tool in global pandemic preparedness. The company’s announcement underscores NV-387’s unique mechanism of action, which mimics heparan sulfate structures, a universal viral binding […]